SealCath is a medical device manufacturing company formed in 2013 by Cephus E. Simmons, Sr to commercialize its colorectal double balloon catheter. The initial design was for the treatment of intussusception in children. With extensive research, additional applications have been identified. The additional applications are barium enema, virtual colonoscopy (CT Colonography), fistulagram, mucous fistula refeed, and CT scan with rectal contrast to evaluate for fistula and post surgical leak. With the listed applications, the SealCath's double balloon catheter has the capability to aid in improving colon cancer screening and the treatment of intussusception in children.